Cervical cancer knowledge and attitude among a cohort of female schoolteachers in Salem city - A cross-sectional survey.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 36387737.
- Also identified by DOI 10.4103/jfmpc.jfmpc_2168_21 and PMC identifier 9648263.
- Licence recorded as CC BY-NC-SA.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The present study aimed to assess the knowledge and attitude of female schoolteachers toward cervical cancer. A cross-sectional study was conducted among 256 Government female schoolteachers aged 22-60 years in Salem city, Tamil Nadu. A self-administered questionnaire which assessed the levels of knowledge (6 items) and attitude (4 items) regarding cervical cancer was employed and responses were recorded on a three-point Likert scale. Data were analysed using Statistical Package for Social Sciences (SPSS) software version 20.0. Overall adequate knowledge and good attitude regards to cervical cancer was observed among 60% and 66.8% of schoolteachers, respectively. Participants in the age range of 31-45 years (p = 0.007), primary schoolteachers (p = 0.004) and Hindus (p = 0.001) displayed significantly adequate levels of knowledge compared to their respective counterpart. Likewise, based on attitude subjects possessing postgraduation (p = 0.001) and middle schoolteachers (p = 0.009) had significant good attitude scores. Significant linear correlation was observed knowledge with class teacher (r = 0.136, <i>P</i> = 0.03) and religion (r = 0.208, <i>P</i> = 0.001) whereas attitude with qualification (r = 0.165, <i>P</i> = 0.008) and class teacher (r = 0.206, <i>P</i> = 0.001) which are positive predictors. Moreover, knowledge had a significant positive correlation with attitude (r = 1.000, <i>P</i> = 0.000). Primary care physicians partnering network with schoolteachers having adequate knowledge and good attitude acts as a workforce to support cervical cancer screening and human papillomavirus vaccination.